Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.65 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 6/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8220107 | 1.00 | ALDH1A1 (0.65) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL4181207 | 1.00 | ALDH1A1 (0.65) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL339893 | 1.00 | ALDH1A1 (0.65) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL4189559 | 1.00 | ALDH1A1 (0.65) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL2696844 | 1.00 | ALDH1A1 (0.65) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL4192038 | 0.98 | ALDH1A1 (0.67) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL234121 | 0.98 | ALDH1A1 (0.67) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL8432037 | 0.98 | ALDH1A1 (0.67) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL233014 | 0.98 | ALDH1A1 (0.67) | ALDH1A1PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL11145051 | 0.98 | ALDH1A1 (0.67) | ALDH1A1PRSS1PRSS2PRSS3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4075173-B1 | METHOD FOR MANUFACTURING LIGHT VALVE AND LIGHT VALVE MANUFACTURED THEREBY | G2B CO LTD (KR) | 2025-02-12 | — | — | EP | claimed |
| US-20230059639-A1 | Method for manufacturing light valve windows and light valve windows manufactured thereby | POSTECH Research and Business Development Foundation (KR) | 2023-02-23 | — | — | US | claimed |
| EP-4075173-A1 | METHOD FOR MANUFACTURING LIGHT VALVE AND LIGHT VALVE MANUFACTURED THEREBY | G2B Co., Ltd. (KR) | 2022-10-19 | — | — | EP | claimed |
| CN-111819233-B | Plasticizer for halogen-based resin | 花王株式会社 | 2022-03-15 | — | — | CN | claimed |
| US-20200339765-A1 | Plastic Articles Containing Suspended Photochromic Dye Molecules | 1-MATERIAL INC (CA) | 2020-10-29 | — | — | US | claimed |
| US-6855741-B2 | Composition for use in flexible polyurethane foams | FERRO CORPORATION (US) | 2005-02-15 | — | — | US | claimed |
| US-20040014830-A1 | Composition for use in flexible polyurethane foams | FERRO CORPORATION (US) | 2004-01-22 | — | — | US | claimed |
| US-20020098242-A1 | Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production | LICONSA, LIBERACION CONTROLADA DE SUSTANCIAS ACTIVAS, S.A. (ES) | 2002-07-25 | — | — | US | claimed |
| WO-2000073368-A1 | COMPOSITION FOR USE IN FLEXIBLE POLYURETHANE FOAMS | SOLUTIA INC. (US) | 2000-12-07 | — | — | WO | claimed |
| US-6004641-A | WHICH HAS THE LOOK AND FEEL OF SUEDE. | SINCLAIR & RUSH, INC. (US) | 1999-12-21 | — | — | US | claimed |
| US-5624968-A | Flexible water-blown polyurethane foams | MONSANTO COMPANY (US) | 1997-04-29 | — | — | US | claimed |
| US-5409734-A | Phase separation of a mixture comprising a homogeneous polymeric solution and a liquid suspension of light-polarizing particles | HANKUK GLASS INDUSTRIES, INC. (KR) | 1995-04-25 | — | — | US | claimed |
| US-5232956-A | Of a polyol and diphenylmethane diisocyanate, and a phthalate, benzoate or phosphate ester plasticizer | MONSANTO COMPANY (US) | 1993-08-03 | — | — | US | claimed |
| WO-1993014425-A1 | LIGHT-POLARIZING LIQUID SUSPENSION, AND METHOD FOR MAKING THE LIQUID SUSPENSION | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-22 | — | — | WO | claimed |
| EP-0551137-A1 | Light-polarizing liquid suspension, and method for making the liquid suspension | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-14 | — | — | EP | claimed |
| US-3931076-A | TRIALKYLACETIC ACID, MELAMINE | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-01-06 | — | — | US | claimed |
| US-12378408-B2 | Plasticizer lignin compositions | EVOCO LTD. (CA) | 2025-08-05 | — | — | US | disclosed |
| US-12337542-B2 | Three-dimensional printing device for printing polyurethane articles | Evoco Limited (CA) | 2025-06-24 | — | — | US | disclosed |
| US-4028328-A | MELAMINE, ANTIPINKING AGENTS SELECTED FROM CARBOXYLIC ACID ESTERS, AND SALTS OF TRIALKYL ACETIC ACIDS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3931076-A | TRIALKYLACETIC ACID, MELAMINE | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020098242-A1 | Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production | SI, ALPI, PGC | ALDH1A1 3674/4885PRSS1 2466/4885PRSS2 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.